# US 2025/0082914 A1 · Swallowable, self-expandable drug delivery device and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082914 A1
- Document ID: US20250082914A1
- Status: Published application
- Kind: A1
- Application number: 18/725,377
- Filed: 2023-01-04
- Published: 2025-03-13
- Earliest claimed: 2022-01-06
- Assignees: ETH Zurich
- Applicants: Eth Zurich
- Inventors: JEAN-CHRISTOPHE LEROUX; ZHI LUO
- Web page: https://patentgrep.com/patent/US20250082914A1

## CPC

- A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/4808: {characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release (capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084)}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A swallowable, foldable and self-expandable oral drug delivery tubular device, the device: comprising an outer peripheral surface; having an expanded length of about 2 cm to about 6 cm; having an expanded diameter of about 0.45 cm to about 6 cm; and comprising at least one cavity enclosing a drug, the at least one cavity facing outward from the outer peripheral surface of the device.

## Claims

### Claim 1

Swallowable, foldable and self-expandable oral drug delivery tubular device, the device:
comprising an outer peripheral surface;
having an expanded length of about 2 cm to about 6 cm;
having an expanded diameter of about 0.45 cm to about 6 cm; and
comprising at least one cavity enclosing a drug, the at least one cavity facing outward from the outer peripheral surface of the device.

### Claim 2 (depends on 1)

The device of claim 1, wherein the tubular device comprises a single tubular mesh.

### Claim 3 (depends on 1)

The device of claim 1, wherein the tubular device comprises foldable guiding members radially extending from a central tube or rod, each foldable guiding member comprising a guiding member outer peripheral surface, the combined guiding member outer peripheral surfaces of all foldable guiding members forming the device's outer peripheral surface.

### Claim 4 (depends on 1)

The device of claim 1, wherein the drug is in a formulation further comprising at least one excipient.

### Claim 5 (depends on 4)

The device of claim 4, wherein the at least one excipient comprises a permeation enhancer.

### Claim 6 (depends on 4)

The device of claim 4, wherein the at least one excipient comprises a protease inhibitor.

### Claim 7 (depends on 1)

The device of claim 1, wherein the drug has a molecular weight of about 1 kDa to about 50 kDa.

### Claim 8 (depends on 1)

The device of claim 1, comprising drug cavities having a volume between 10 nl and 100 μL.

### Claim 9 (depends on 1)

The device of claim 1, wherein the device material comprises or consists of an elastomer.

### Claim 10 (depends on 1)

Enteric capsule enclosing the device defined in claim 1.

### Claim 11 (depends on 10)

The capsule of claim 10, further comprising a filler.

### Claim 12 (depends on 1)

The device of claim 1, for oral administration of the drug to a subject.

### Claim 13 (depends on 12)

The device of capsule of claim 12, wherein the subject is a human and the device's expanded diameter is of about 1.1 cm to about 6 cm.

### Claim 14 (depends on 1)

A method of using the device as defined in claim 1 enclosed in an enteric capsule, for the oral administration of the drug to a subject, the use comprising:
orally administering the capsule to the subject, whereby when the capsule releases the device in the small intestine, the device self-expands and positions itself coaxially in the intestine, and
whereby the drug migrates through the intestine epithelium and enters systemic circulation of the subject.

### Claim 15 (depends on 14)

The use of claim 14, wherein the subject is a human.

### Claim 16 (depends on 1)

A capsule enclosing the device defined in claim 1, for oral administration of the drug to a subject.
